Atlas Trials

The Combination of Immunotherapy and Stereotactic Ablative Radiotherapy in MSS Oligometastatic Colorectal Cancer

Clinical trial NCT04535024 · UNKNOWN

Trial details

NCT number
NCT04535024
Sponsor
Fudan University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Colorectal Cancer
Start date
2021-03-04
Primary completion
2022-06-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.